Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] NLMUID: 101140988"" wg kryterium: JN


Tytuł :
Myofibrosarcoma infiltrating pulmonary arteries diagnosed on F-FDG PET/CT.
Autorzy :
Wei W; Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Chen Y; Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhao X; Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Liu J; Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. .
Cao M; Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Preclinical characterization of [ F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase.
Autorzy :
Koike T; Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi, 2-Chome, Fujisawa, Kanagawa, 251-8555, Japan. .
Constantinescu CC; Invicro, LLC, New Haven, CT, USA.
Ikeda S; Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi, 2-Chome, Fujisawa, Kanagawa, 251-8555, Japan.
Nishi T; Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi, 2-Chome, Fujisawa, Kanagawa, 251-8555, Japan.
Sunahara E; Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi, 2-Chome, Fujisawa, Kanagawa, 251-8555, Japan.
Miyamoto M; Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi, 2-Chome, Fujisawa, Kanagawa, 251-8555, Japan.
Cole P; Takeda Pharmaceuticals International Co, Cambridge, MA, USA.
Barret O; Invicro, LLC, New Haven, CT, USA.
Alagille D; Invicro, LLC, New Haven, CT, USA.
Papin C; Invicro, LLC, New Haven, CT, USA.
Morley T; Invicro, LLC, New Haven, CT, USA.
Fowles K; Yale PET Center, New Haven, CT, USA.
Seibyl J; Invicro, LLC, New Haven, CT, USA.
Tamagnan G; Invicro, LLC, New Haven, CT, USA.; Yale PET Center, New Haven, CT, USA.
Kuroita T; Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi, 2-Chome, Fujisawa, Kanagawa, 251-8555, Japan.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
New technologies-the best is yet to come.
Autorzy :
Pini C; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4Pieve Emanuele, 20090, Milan, Italy.; Department of Nuclear Medicine, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy.
Chiti A; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4Pieve Emanuele, 20090, Milan, Italy. .; Department of Nuclear Medicine, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's disease.
Autorzy :
Bertoglio D; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium.; μNEURO Research Centre of Excellence, University of Antwerp, Antwerp, Belgium.
Verhaeghe J; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium.
Miranda A; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium.
Wyffels L; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium.; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.
Stroobants S; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium.; μNEURO Research Centre of Excellence, University of Antwerp, Antwerp, Belgium.; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.
Mrzljak L; CHDI Management/CHDI Foundation, Los Angeles, CA, USA.
Khetarpal V; CHDI Management/CHDI Foundation, Los Angeles, CA, USA.
Skinbjerg M; CHDI Management/CHDI Foundation, Los Angeles, CA, USA.
Liu L; CHDI Management/CHDI Foundation, Los Angeles, CA, USA.
Dominguez C; CHDI Management/CHDI Foundation, Los Angeles, CA, USA.
Munoz-Sanjuan I; CHDI Management/CHDI Foundation, Los Angeles, CA, USA.
Bard J; CHDI Management/CHDI Foundation, Los Angeles, CA, USA.
Staelens S; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium. .; μNEURO Research Centre of Excellence, University of Antwerp, Antwerp, Belgium. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pharmacokinetic and pharmacodynamic assessment of histamine H 3 receptor occupancy by enerisant: a human PET study with a novel H 3 binding ligand, [ C]TASP457.
Autorzy :
Kimura Y; Department of Functional Brain Imaging, Institute for Quantum Medical Science , National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan.; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, 7-430 Morioka, Obu, Aichi, 474-8511, Japan.
Takahata K; Department of Functional Brain Imaging, Institute for Quantum Medical Science , National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan.
Shimazaki T; Taisho Pharmaceutical Co, Ltd. 3-24-1 Takada, Toshima-ku, Tokyo, 170-8633, Japan.
Kitamura S; Department of Functional Brain Imaging, Institute for Quantum Medical Science , National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan.
Seki C; Department of Functional Brain Imaging, Institute for Quantum Medical Science , National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan.
Ikoma Y; Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science , National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Ichise M; Department of Functional Brain Imaging, Institute for Quantum Medical Science , National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan.; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, 7-430 Morioka, Obu, Aichi, 474-8511, Japan.
Kawamura K; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science , National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage, Chiba, Chiba, 263-8555, Japan.
Yamada M; Department of Functional Brain Imaging, Institute for Quantum Medical Science , National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan.
Zhang MR; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science , National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage, Chiba, Chiba, 263-8555, Japan.
Higuchi M; Department of Functional Brain Imaging, Institute for Quantum Medical Science , National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan. .
Nishino I; Taisho Pharmaceutical Co, Ltd. 3-24-1 Takada, Toshima-ku, Tokyo, 170-8633, Japan.
Suhara T; Department of Functional Brain Imaging, Institute for Quantum Medical Science , National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, Chiba, 263-8555, Japan.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [ F]FDG PET-CT studies performed in oncologic patients.
Autorzy :
Cohen D; Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann St, 6423906, Tel Aviv, Israel.
Hazut Krauthammer S; Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann St, 6423906, Tel Aviv, Israel.
Wolf I; Institute of Oncology, Tel-Aviv Sourasky Medical Center, 6 Weizmann St, 6423906, Tel Aviv, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Even-Sapir E; Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann St, 6423906, Tel Aviv, Israel. .; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Imaging of cardiac fibroblast activation in patients with chronic thromboembolic pulmonary hypertension.
Autorzy :
Chen BX; Department of Nuclear Medicine, Beijing Chaoyang Hospital, Capital Medical University, 8th Gongtinanlu Rd, Chaoyang District, Beijing, 100020, China.
Xing HQ; Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, 100730, China.
Gong JN; Department of Respiratory and Critical Care, Beijing Chaoyang Hospital, Capital Medical University, 8th Gongtinanlu Rd, Chaoyang District, Beijing, 100020, China.; Beijing Institute of Respiratory Medicine, Beijing, 100020, China.
Guo XJ; Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Xi XY; Department of Nuclear Medicine, Beijing Chaoyang Hospital, Capital Medical University, 8th Gongtinanlu Rd, Chaoyang District, Beijing, 100020, China.
Yang YH; Department of Respiratory and Critical Care, Beijing Chaoyang Hospital, Capital Medical University, 8th Gongtinanlu Rd, Chaoyang District, Beijing, 100020, China.; Beijing Institute of Respiratory Medicine, Beijing, 100020, China.
Huo L; Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, 100730, China.
Yang MF; Department of Nuclear Medicine, Beijing Chaoyang Hospital, Capital Medical University, 8th Gongtinanlu Rd, Chaoyang District, Beijing, 100020, China. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Deep learning radiomics of dual-energy computed tomography for predicting lymph node metastases of pancreatic ductal adenocarcinoma.
Autorzy :
An C; Department of Minimal Invasive Intervention, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Li D; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, the State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
Li S; Department of Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Li W; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Tong T; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, the State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, 100049, China.
Liu L; Department of Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Jiang D; Department of Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Jiang L; Department of Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Ruan G; Department of Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Hai N; Department of Ultrasound, Beijing Chao Yang Hospital, Capital Medical University, Beijing, 100010, China.
Fu Y; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Wang K; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, the State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China. .; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, 100049, China. .
Zhuo S; Department of Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. .
Tian J; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China. .; CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, the State Key Laboratory of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China. .; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, 100049, China. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The prognostic value of end-of-treatment FDG-PET/CT in diffuse large B cell lymphoma: comparison of visual Deauville criteria and a lesion-to-liver SUV max ratio-based evaluation system.
Autorzy :
Li YH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.; Department of Nuclear Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, Guangdong, China.
Zhao YM; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.; Department of Nuclear Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, Guangdong, China.
Jiang YL; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.; Department of Nuclear Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, Guangdong, China.
Tang S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.; Department of Nuclear Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, Guangdong, China.
Chen MT; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
Xiao ZZ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.; Department of Nuclear Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, Guangdong, China.
Fan W; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China. .; Department of Nuclear Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, Guangdong, China. .
Hu YY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China. .; Department of Nuclear Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, Guangdong, China. .
Zhang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China. .; Department of Nuclear Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, Guangdong, China. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Proof of concept of a multimodal intravital molecular imaging system for tumour transpathology investigation.
Autorzy :
Liu Z; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.; Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, China.
Cheng T; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
Düwel S; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
Jian Z; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
Topping GJ; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
Steiger K; Department of Pathology, School of Medicine, Technische Universität München, Munich, Germany.
Wang Q; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
Braren R; Department of Radiology, Technische Universität München, Munich, Germany.
Reder S; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
Mittelhäuser M; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
Hundshammer C; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
Feuerecker B; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
Huang SC; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, USA.
Schwaiger M; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
Schilling F; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
Ziegler SI; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.; Department of Nuclear Medicine, University Hospital LMU Munich, Munich, Germany.
Shi K; Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany. .; Department of Nuclear Medicine, University of Bern, Bern, Switzerland. .; Department of Informatics, Technische Universität München, Munich, Germany. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes.
Autorzy :
Nazari M; Faculty of Computer Science and Center for Molecular and Cellular Bioengineering, Technical University Dresden, BiotechDresden, Germany.; ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft M.B.H, 01307, Dresden, Germany.
Kluge A; ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft M.B.H, 01307, Dresden, Germany.
Apostolova I; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Klutmann S; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Kimiaei S; ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft M.B.H, 01307, Dresden, Germany.
Schroeder M; Center for Molecular and Cellular Bioengineering, Technical University Dresden, Dresden, Germany.
Buchert R; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer's disease.
Autorzy :
Massa F; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Daneo 3, 16132, Genoa, Italy. .
Chincarini A; National Institute of Nuclear Physics (INFN), Genoa section, Genoa, Italy.
Bauckneht M; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Raffa S; Department of Health Science (DISSAL), University of Genoa, Genoa, Italy.
Peira E; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Daneo 3, 16132, Genoa, Italy.; National Institute of Nuclear Physics (INFN), Genoa section, Genoa, Italy.
Arnaldi D; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Daneo 3, 16132, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Pardini M; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Daneo 3, 16132, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Pagani M; Institute of Cognitive Sciences and Technologies, Consiglio Nazionale Delle Ricerche (CNR), Rome, Italy.; Department of Medical Radiation Physics and Nuclear Medicine, Karolinska Hospital, Stockholm, Sweden.
Orso B; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Daneo 3, 16132, Genoa, Italy.
Donegani MI; Department of Health Science (DISSAL), University of Genoa, Genoa, Italy.
Brugnolo A; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Daneo 3, 16132, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Biassoni E; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Daneo 3, 16132, Genoa, Italy.
Mattioli P; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Daneo 3, 16132, Genoa, Italy.
Girtler N; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Daneo 3, 16132, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Guerra UP; Formerly at Nuclear Medicine Unit, Fondazione Poliambulanza, Brescia, Italy.
Morbelli S; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Department of Health Science (DISSAL), University of Genoa, Genoa, Italy.
Nobili F; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Largo Daneo 3, 16132, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Positron emission tomography and computed tomography with [ Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer.
Autorzy :
Pang Y; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Zhao L; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Shang Q; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Meng T; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Zhao L; Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Feng L; Department of Hepatobiliary & Pancreatovascular Surgery, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Wang S; Department of Hepatobiliary & Pancreatovascular Surgery, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Guo P; Department of Hepatobiliary & Pancreatovascular Surgery, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Wu X; Department of Radiology, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Lin Q; Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Wu H; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China.
Huang W; Department of Nuclear Medicine, Jieyang Affiliated Hospital, Sun Yat-Sen University, Jieyang, China. .
Sun L; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China. .
Chen H; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, China. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [ F]FDG PET/CT.
Autorzy :
Zhang X; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
Chen L; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
Jiang H; PET-CT Center, Fujian Medical University Union Hospital, Fuzhou, China.
He X; Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Feng L; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
Ni M; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
Ma M; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
Wang J; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
Zhang T; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
Wu S; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
Zhou R; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
Jin C; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
Zhang K; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
Qian W; Department of Hematology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Chen Z; Department of Clinical Epidemiology & Biostatistics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Zhuo C; College of Information Science & Electronic Engineering, Zhejiang University, Hangzhou, China.
Zhang H; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China. .; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China. .; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China. .; Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, Hangzhou, China. .; College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China. .
Tian M; Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China. .; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China. .; Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China. .; Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, Hangzhou, China. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 15. Date of Electronic Publication: 2021 Oct 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Hybrid total-body pet scanners-current status and future perspectives.
Autorzy :
Nadig V; Department of Physics of Molecular Imaging Systems, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany.
Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, Duisburg, Germany.; German Cancer Consortium (DKTK) - University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Mottaghy FM; Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Schulz V; Department of Physics of Molecular Imaging Systems, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. .; Hyperion Hybrid Imaging Systems GmbH, Aachen, Germany. .; Physics Institute III B, RWTH Aachen University, Aachen, Germany. .; Fraunhofer Institute for Digital Medicine MEVIS, Aachen, Germany. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 14. Date of Electronic Publication: 2021 Oct 14.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
EC 50 images, a novel endpoint from PET target occupancy studies, reveal spatial variation in apparent drug affinity.
Autorzy :
de Laat B; Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.
Hoye J; Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.
Liu H; Department of Biomedical Engineering, Yale University, CT, New Haven, USA.
Morris ED; Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA. .; Department of Psychiatry, Yale University, New Haven, CT, USA. .; Department of Biomedical Engineering, Yale University, CT, New Haven, USA. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 12. Date of Electronic Publication: 2021 Oct 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Targeted optical fluorescence imaging: a meta-narrative review and future perspectives.
Autorzy :
Schouw HM; Department of Surgery, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Huisman LA; Department of Surgery, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Janssen YF; Department of Surgery, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Slart RHJA; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; Department of Biomedical Photonic Imaging, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.
Borra RJH; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; Department of Radiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Willemsen ATM; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
van Dijl JM; Department of Medical Microbiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Dierckx RA; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; Department of Diagnostic Sciences, Ghent University Faculty of Medicine and Health Sciences, Gent, Belgium.
van Dam GM; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; AxelaRx/TRACER Europe BV, Groningen, The Netherlands.
Szymanski W; Department of Radiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Boersma HH; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre of Groningen, Groningen, The Netherlands.
Kruijff S; Department of Surgery, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands. .; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 11. Date of Electronic Publication: 2021 Oct 11.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.
Autorzy :
Rogowski P; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. .
Trapp C; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
von Bestenbostel R; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Eze C; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Ganswindt U; Department of Radiation Oncology, University Hospital, Medical University Innsbruck, Innsbruck, Austria.
Li M; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Unterrainer M; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Zacherl MJ; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Ilhan H; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Beyer L; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Kretschmer A; Department of Urology, University Hospital, LMU Munich, Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Stief C; Department of Urology, University Hospital, LMU Munich, Munich, Germany.
Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Munich, Germany.
Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 10. Date of Electronic Publication: 2021 Oct 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms.
Autorzy :
Borgna F; Center for Radiopharmaceutical Sciences, ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
Haller S; Center for Radiopharmaceutical Sciences, ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
Rodriguez JMM; Laboratory for Animal Model Pathology, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, 8057, Zurich, Switzerland.
Ginj M; The Joint Department of Medical Imaging, University Health Network, 200 Elizabeth St, Toronto, ON, M5G 2C4, Canada.
Grundler PV; Center for Radiopharmaceutical Sciences, ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
Zeevaart JR; South African Nuclear Energy Corporation (Necsa), Pelindaba, Brits, 0240, South Africa.
Köster U; Institut Laue-Langevin, 38042, Grenoble, France.
Schibli R; Center for Radiopharmaceutical Sciences, ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.; Department of Chemistry and Applied Biosciences, ETH Zurich, 8093, Zurich, Switzerland.
van der Meulen NP; Center for Radiopharmaceutical Sciences, ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.; Laboratory of Radiochemistry, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
Müller C; Center for Radiopharmaceutical Sciences, ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland. .; Department of Chemistry and Applied Biosciences, ETH Zurich, 8093, Zurich, Switzerland. .
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 08. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
[ Lu]Lu-PSMA-617 treatment.
Autorzy :
Peters SMB; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. .
Hofferber R; Department of Nuclear Medicine, Essen University Hospital, Essen, Germany.
Privé BM; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
de Bakker M; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Gotthardt M; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Janssen M; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
de Lange F; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Muselaers CHJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Costa PF; Department of Nuclear Medicine, Essen University Hospital, Essen, Germany.
Nagarajah J; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Konijnenberg MW; Department of Medical Imaging, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.
Jentzen W; Department of Nuclear Medicine, Essen University Hospital, Essen, Germany.
Pokaż więcej
Źródło :
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Oct 08. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies